|Articles|April 13, 2016

Implications of Mid-Study Clinical Trial Protocol Changes

Medidata & Tufts Center for the Study of Drug Development announced results of a study on the impact of protocol amendmends made while a clinical trial is underway. The study discussed their avoidability, costs and time delays.

Read the full release here

Read more in Kenneth Getz’s column this month here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content